Valid for Submission
B44.0 is a billable diagnosis code used to specify a medical diagnosis of invasive pulmonary aspergillosis. The code B44.0 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The ICD-10-CM code B44.0 might also be used to specify conditions or terms like deep mycosis, invasive aspergillosis, invasive fungal infection, invasive pulmonary aspergillosis, pulmonary aspergillosis , subacute invasive pulmonary aspergillosis, etc.
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code B44.0 are found in the index:
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Deep mycosis
- Invasive aspergillosis
- Invasive fungal infection
- Invasive pulmonary aspergillosis
- Pulmonary aspergillosis
- Subacute invasive pulmonary aspergillosis
- INVASIVE PULMONARY ASPERGILLOSIS-. lung infections with the invasive forms of aspergillus usually after surgery transplantation prolonged neutropenia or treatment with high doses of corticosteroids. invasive pulmonary aspergillosis can progress to chronic necrotizing pulmonary aspergillosis or hematogenous spread to other organs.
Diagnostic Related Groups - MS-DRG Mapping
|MS-DRG||MS-DRG Title||MCD||Relative Weight|
|177||RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC||04||1.8453|
|178||RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH CC||04||1.2059|
|179||RESPIRATORY INFECTIONS AND INFLAMMATIONS WITHOUT CC/MCC||04||0.8711|
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
Convert B44.0 to ICD-9 Code
Information for Patients
Aspergillosis is a disease caused by a fungus (or mold) called Aspergillus. The fungus is very common in both indoors and outdoors. Most people breathe in the spores of the fungus every day without being affected. But some people get the disease. It usually occurs in people with lung diseases or weakened immune systems.
There are different kinds of aspergillosis. One kind is allergic bronchopulmonary aspergillosis (also called ABPA). Symptoms of ABPA include wheezing and coughing. ABPA can affect healthy people but it is most common in people with asthma or cystic fibrosis.
Another kind is invasive aspergillosis, which damages tissues in the body. It usually affects the lungs. Sometimes it can also cause infection in other organs and spread throughout the body. It affects people who have immune system problems, such as people who have had a transplant, are taking high doses of steroids, or getting chemotherapy for some cancers.
Your doctor might do a variety of tests to make the diagnosis, including a chest x-ray, CT scan of the lungs, and an examination of tissues for signs of the fungus. Treatment is with antifungal drugs. If you have ABPA, you may also take steroids.
Centers for Disease Control and Prevention
[Learn More in MedlinePlus]